Transmedics Group, Inc. Public Market Comparables
Find the most relevant public market comparables for Transmedics Group, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
TransMedics Group, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. They developed the Organ Care System (OCS) to replace a decades-old standard of care, aiming to significantly increase access to life-saving transplant therapy. The OCS replicates many aspects of an organ's natural living and functioning environment outside the human body.
Business Model
Development and commercialization of the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that preserves and delivers human organs for transplant in a near-physiologic condition.
Target Customers
Hospitals and transplant centers performing heart, lung, and liver transplants.
Specific Focus
Portable extracorporeal warm perfusion and assessment of donor organs for transplantation.
Location
Andover, Massachusetts
CEO
Dr. Waleed Hassanein
Industry
Life sciences
Sub Sector
Organ Preservation and Transplantation
3yr Revenue Growth
842%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Transmedics Group, Inc. in the Medical Technology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Transmedics Group, Inc.? Our platform provides detailed analysis of Transmedics Group, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Transmedics Group, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Transmedics Group, Inc. Compset
As a leading player in the Life sciences industry within the Medical Technology sector, Transmedics Group, Inc. operates in the specialized Organ Preservation and Transplantation sub-sector. Understanding how Transmedics Group, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Organ Preservation and Transplantation space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Gyre Therapeutics, Inc.
Pharmaceuticals & Biotech • Life sciences
A commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of drugs for organ fibrosis. They develop and commercialize small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, specifically organ fibrosis. The company has commercial-stage products and a diverse pipeline of drug candidates, operating in both the US and China.
Akido Labs
Healthcare • Life sciences
Akido Labs is an AI and care delivery company reimagining healthcare with a focus on using AI to improve access and quality of care. They have developed ScopeAI, an AI system that increases clinical capacity and improves healthcare access, aiming to address physician shortages and improve patient care.
CVRx Inc.
Medical Devices • Life sciences
CVRx is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, uses neuromodulation to improve the symptoms of heart failure and hypertension by leveraging the body's natural reflex to regulate blood pressure.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Transmedics Group, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free